ScholarLens Back to search
2023•Neuromuscular DisordersRequires access

P62 SIMPATHIC: accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology

P. 't Hoen, L. Benkemoun, Alessandro Prigione, Ibrahim Boussaad, Martin de Kort, A. Geille, Hanns Lochmüller, Nicol Cornelia Voermans, Baziel G.M. van Engelen, Clara van Karnebeek

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Repurposing, Drug repositioning, Drug development, Clinical trial, Medicine, Approved drug, Drug, Drug discovery

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
P62 SIMPATHIC: accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology — Research Paper | ScholarLens